Cell SystemsSystems BiologyPeer-reviewed journal article
A Library of Phosphoproteomic and Chromatin Signatures for Characterizing Cellular Responses to Drug Perturbations
Lev LitichevskiyiD, Ryan Peckner, Jennifer G. AbeliniD, Jacob K. Asiedu, Amanda L. CreechiD, John F. Davis, Desiree Davison, Caitlin M. Dunning, Jarrett D. EgertsoniD, Shawn B. EgriiD, Joshua GouldiD, Tak Ko, Sarah JohnsoniD, David L. LahriD, Daniel Lam, Zihan LiuiD, Nicholas J. Lyons, Xiaodong LüiD, Brendan MacLeaniD, Alison E. MungenastiD, Adam Officer, Ted E. NatoliiD, Malvina PapanastasiouiD, Jinal Patel, Vagisha SharmaiD, , Jacob D. JaffeiD
Abstract
Though the added value of proteomic measurements to gene expression profiling has been demonstrated, profiling of gene expression on its own remains the dominant means of understanding cellular responses to perturbation. Direct protein measurements are typically limited due to issues of cost and scale; however, the recent development of high-throughput, targeted sentinel mass spectrometry assays provides an opportunity for proteomics to contribute at a meaningful scale in high-value areas for drug development. To demonstrate the feasibility of a systematic and comprehensive library of perturbational proteomic signatures, we profiled 90 drugs (in triplicate) in six cell lines using two different proteomic assays -- one measuring global changes of epigenetic marks on histone proteins and another measuring a set of peptides reporting on the phosphoproteome -- for a total of more than 3,400 samples. This effort represents a first-of-its-kind resource for proteomics. The majority of tested drugs generated reproducible responses in both phosphosignaling and chromatin states, but we observed differences in the responses that were cell line-and assay-specific. We formalized the process of comparing response signatures within the data using a concept called connectivity, which enabled us to integrate data across cell types and assays. Furthermore, it facilitated incorporation of transcriptional signatures. Consistent connectivity among cell types revealed cellular responses that transcended cell-specific effects, while consistent connectivity among assays revealed unexpected associations between drugs that were confirmed by experimental follow-up. We further demonstrated how the resource could be leveraged against public domain external datasets to recognize therapeutic hypotheses that are consistent with ongoing clinical trials for the treatment of multiple myeloma and acute lymphocytic leukemia (ALL). These data are available for download via the Gene Expression Omnibus (accession GSE101406), and web apps for interacting with this resource are available at https://clue.io/proteomics.\n\nHighlightsO_LIFirst-of-its-kind public resource of proteomic responses to systematically administered perturbagens\nC_LIO_LIDirect proteomic profiling of phosphosignaling and chromatin states in cells for 90 drugs in six different cell lines\nC_LIO_LIExtends Connectivity Map concept to proteomic data for integration with transcriptional data\nC_LIO_LIEnables recognition of unexpected, cell type-specific activities and potential translational therapeutic opportunities\nC_LI
- Citations
- 87
- FWCI
- 5.18
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Large-scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines
Wei Zhao, Jun Li, … Han Liang·Cancer CellPeer-reviewed·Nov 5, 2020
- RegulomeXplorer: Interactive exploration of drug effects on subcellularly resolved proteomes
Matthias Uiberacker, Thomas Iellici, … Jürgen Zanghellini·bioRxiv·Jul 3, 2026
- Drug-Prot: A query system for statistical inference of drug effects and interactions in dynamic proteomic networks
Markus Ulmer, Rui Sun, … Peter Bühlmann·bioRxiv·Jun 22, 2026
- Drug Response Modeling across Cancers: Proteomics vs. Transcriptomics
Zetian Zheng, Lei Huang, … Ka‐Chun Wong·bioRxiv·Dec 4, 2024
- Compound Mechanism of Action and Polypharmacology can be Elucidated by Large-Scale Perturbational Profile Analysis
Lucas ZhongMing Hu, Tal Hirschhorn, … Andrea Califano·bioRxiv·Oct 8, 2023
- Signatures of cell death and proliferation in perturbation transcriptomics data - from confounding factor to effective prediction
Bence Szalai, Vigneshwari Subramanian, … Julio Sáez-Rodríguez·Nucleic Acids ResearchPeer-reviewed·Sep 12, 2019